Skip to main content
. 2019 Feb 21;9:100. doi: 10.3389/fonc.2019.00100

Figure 2.

Figure 2

WGA binds and kills in a dose- and time-dependent manner. (A) OCI-AML3 cells treated with WGA-FITC (500 ng/mL) and analyzed for binding using flow cytometry. Binding to cells at 45 min (blue peak) and 24 h (red peak) compared to control (black peak). (B) OCI-Ly10 and HL-60 cells treated with WGA-FITC (500 ng/mL) for 30 min and analyzed for binding using flow cytometry. (C,D) Viable cell count and percent viability of HL-60 (C) and (D) OCI-AML3 with WGA treatment (0.5, 1.0, 2.0, and 4.0 μg/mL) for 1–4 days, counted using trypan blue. ***p < 0.001.